Latest / AVBCC Value-Based Voices

Ted Slafsky on 340B's Triple Threat: CMS Cuts, the Rebate Model Fight & Contract Pharmacy in Court
CMS has just finalized a cut to hospital payments for 340B drugs, from ASP+6% down to ASP-28%. The lawsuits are already on the way. Host Jayson Slotnik sits down with Ted Slafsky, Publisher and CEO of the 340B Report, to break down three fast-moving 340B fights: the new CMS reimbursement decision, the hospital lawsuit against HRSA's 340B rebate model (oral arguments November 18 in Portland, Maine), and the circuit split over state contract pharmacy laws now before the full Fourth Circuit. Ted also gives his predictions on how each case will turn out.
Want to know if Ted's predictions come…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.